ARCA biopharma Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$8.54 |
Market Cap |
$7.63 M |
Shares Outstanding |
1.41 M |
Public Float |
13.75 M |
Address |
11080 CirclePoint Road Westminster Colorado 80020 United States |
Employees | - |
Website | http://www.arcabiopharma.com |
Updated | 07/08/2019 |
ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. |